Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
23andMe Holding Co. | Chief Therapeutics Officer | Class A Common Stock | 222K | $159K | $0.72 | Jun 5, 2023 | Direct |
SANGAMO THERAPEUTICS, INC | Director | Common Stock | 74.6K | $44.8K | $0.60 | Jun 4, 2024 | Direct |
SANGAMO THERAPEUTICS, INC | Director | Stock Option (Right to Buy) | 50K | Jun 4, 2024 | Direct | ||
Zymeworks Inc. | Director | Stock Option (Right to Buy) | 37K | Dec 7, 2023 | Direct | ||
Zymeworks Inc. | Director | Stock Option (Right to Buy) | 9K | May 6, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SGMO | SANGAMO THERAPEUTICS, INC | Jun 4, 2024 | 2 | $0 | 4 | Jun 6, 2024 | Director |
ZYME | Zymeworks Inc. | Dec 7, 2023 | 1 | $0 | 4 | Dec 8, 2023 | Director |
ME | 23andMe Holding Co. | Jun 5, 2023 | 2 | -$31.9K | 4 | Jun 7, 2023 | Chief Therapeutics Officer |
SGMO | SANGAMO THERAPEUTICS, INC | Jun 1, 2023 | 2 | $0 | 4 | Jun 5, 2023 | Director |
ME | 23andMe Holding Co. | May 20, 2023 | 1 | -$8.98K | 4 | May 23, 2023 | Chief Therapeutics Officer |
ME | 23andMe Holding Co. | Feb 20, 2023 | 1 | -$15.7K | 4 | Feb 22, 2023 | Chief Therapeutics Officer |
ZYME | Zymeworks Inc. | Dec 21, 2022 | 1 | $0 | 4 | Dec 23, 2022 | Director |
ME | 23andMe Holding Co. | Nov 20, 2022 | 1 | -$13.8K | 4 | Nov 22, 2022 | Chief Therapeutics Officer |
ME | 23andMe Holding Co. | Aug 24, 2022 | 1 | -$31.9K | 4 | Aug 25, 2022 | Chief Therapeutics Officer |
ME | 23andMe Holding Co. | Aug 20, 2022 | 1 | -$15.4K | 4 | Aug 22, 2022 | Chief Therapeutics Officer |
ME | 23andMe Holding Co. | Jun 1, 2022 | 1 | -$13K | 4 | Jun 2, 2022 | Chief Therapeutics Officer |
SGMO | SANGAMO THERAPEUTICS, INC | Feb 25, 2022 | 2 | $0 | 4 | Mar 1, 2022 | Director |
ME | 23andMe Holding Co. | Feb 9, 2022 | 2 | $0 | 4 | Feb 11, 2022 | Head of Therapeutics |
ME | 23andMe Holding Co. | Jun 16, 2021 | 0 | $0 | 3 | Jun 25, 2021 | Head of Therapeutics |
ZYME | Zymeworks Inc. | May 6, 2021 | 1 | $0 | 4 | May 7, 2021 | Director |